Institutional Perspectives in Cancer: Gynecologic Cancers - Chaired by Ursula A. Matulonis, MD

Commentary
Video

Institutional Perspectives in Cancer: Gynecologic Cancers - Chaired by Ursula A. Matulonis, MD

The live filming of this virtual event in our IPC series is now on-demand.

OncLive is proud to present the State of the Science Summits and a new virtual event, Institutional Perspectives in Cancer (IPC). Each summit and webinar will convene for a short meeting designed to educate healthcare professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches, but also leave the event the with confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each event is dedicated to the latest research in one of the following therapeutic areas: Breast Cancer, Lung Cancer, GU & Prostate Cancer, Hematology, or Melanoma.

The State of the Science Summits and IPC assemble academic and community-based physicians & healthcare professionals across key disciplines from medical and surgical oncology. Specialist experts serve as faculty for these premier and renowned oncology summits, which focus on the most relevant cancer topics to ultimately improve patient care.

Speakers

  • Elizabeth Stover, MD, PhD | Dana-Farber Cancer Institute
  • Rebecca Porter, MD, PhD | Dana-Farber Cancer Institute
  • Elizabeth Lee, MD | Dana-Farber Cancer Institute
  • Ursula A. Matulonis, MD | Dana-Farber Cancer Institute

Topics

  • PARPs in Ovarian Cancer
  • ADCs in Ovarian
  • Future Directions in Ovarian Cancer
  • Recent Updates in Endometrial Cancer
  • Case Based Discussion: Endometrial Cancer

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
A panel of 4 experts on chronic graft-versus-host disease
A panel of 4 experts on chronic graft-versus-host disease
A panel of 6 experts on follicular lymphoma and mantle cell lymphoma seated at a long desk
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, David M. Livingston, MD, Chair, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
Harriet Kluger, MD, Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; director, Yale SPORE in Skin Cancer; vice chair, Translational Research, Internal Medicine; chief, Division of Skin and Kidney Cancer; associate cancer center director, Education, Training and Faculty Development; deputy section chief, Medical Oncology, Yale Cancer Center
A panel of 4 experts on chronic graft-versus-host disease
A panel of 4 experts on chronic graft-versus-host disease
Michael Hagensee, MD, PhD, Louisiana State University Health, New Orleans School of Medicine